Sage Therapeutics said in a release that 64 percent of patients achieved Major Depression Disorder remission using the SAGE-217 drug in the 15th day of treatment. Read the article here.
Biotech Sage Therapeutics Skyrockets More Than 70 Percent After Depression Drug Breakthrough
